StockData
Vireo Growth Inc. logo

Vireo Growth Inc. (VREOF) stock

VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30
$9.01+0.01 (+0.11%)

Close on Oct 19, 2026Market cap $443.48MP/E –Yield –

Vireo Growth r&d expenses

Research and development expenses are spending on new products and technology.

No r&d expenses figures for Vireo Growth

Vireo Growth has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Vireo Growth figures

See a number that looks wrong?